iopentol has been researched along with Local Neoplasm Recurrence in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beheshti, M; Dirisamer, A; Flöry, D; Halpern, BS; Langsteger, W; Mayerhoefer, ME; Wolf, F | 1 |
| Clavien, PA; Hany, TF; Kadry, Z; McCormack, L; Selzner, M; Wildbrett, P | 1 |
2 other study(ies) available for iopentol and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Integrated contrast-enhanced diagnostic whole-body PET/CT as a first-line restaging modality in patients with suspected metastatic recurrence of breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Systems Integration; Tomography, X-Ray Computed; Triiodobenzoic Acids; Whole Body Imaging | 2010 |
Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver?
Topics: Colorectal Neoplasms; Contrast Media; Databases, Factual; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Triiodobenzoic Acids | 2004 |